DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment



Oncology Homepage

CIVCO Radiotherapy and Adaptiiv ink distribution deal Partnership will increase access to software that personalizes radiotherapy

California hospital first in country to perform a robotic bronchoscopy procedure Part of Monarch Platform clinical trial

Global CT scanner market to exceed $7 billion by 2024 Cone beam technology is driving the industry

Varian updates cancer imaging software with SIRT dosimetry capabilities Better comprehension of tumor response and normal-tissue toxicity

Proton therapy arrives in the UK First British patient has undergone a bout of proton therapy in South Wales

New camera inspired by butterfly eyes helps surgeons remove all cancerous tissue May cost as little as $200

RefleXion raises $100 million for world’s first biology-guided radiotherapy system Will be designed to irradiate multiple tumors in one session

Cheryl DuBose and David C. Madoff ARRT board of trustees appoints new members

Global critical care diagnostics market driven by rise in chronic and infectious diseases Report predicts CAGR of over six percent through 2022

MedStar Georgetown treats first patients with MEVION S250i proton therapy Two other installations planned for later this year

How Mayo Clinic and IBM Watson dramatically improved clinical trial enrollment

by John R. Fischer , Staff Reporter
With a little help from IBM Watson enrollment in breast cancer-specific drug trials at Mayo Clinic went up by 80 percent in less than a year, according to Dr. Tufia Haddad

The associate professor of oncology at Mayo Clinic elaborated on that success during a presentation at HIMSS 2018 in Las Vegas, crediting it, (as well as a reduction in screening time) to IBM Watson Health’s Watson for Clinical Trial Matching AI cognitive computing system.

Story Continues Below Advertisement

The (#1 Resource) for Medical Imaging and Peripherals. Call 1-949-273-8000

As a Master Distributor for major brands Barco, Philips, and Sony, we offer custom imaging solutions. With our renowned OEM Solutions and Service/Repair Center, Ampronix is a one-stop shop for HD Medical LCD Displays--Printers--Recorders--4K Cameras

“When we started in 2014, everything was manually entered. It was taking up to three minutes in order to drive patient and tumor attributes. We were using all data from electronic health records, and natural language processing was quite limited,” she said. “Today, we’re able to drive nearly all unstructured and in some cases, structured data. The time to get these patient attributes is literally in a single click. In less than a second, all this information comes forward. We have limited our data to oncology-specific notes: surgery, radiation, medical therapies for cancer treatment, pathology reports-specific. We’re not utilizing our entire EHR.”

Only about 5 percent of all cancer patients in the U.S. take part in clinical trials, that very low participation rate leads to incomplete research that delays access to better therapies and improvements in patient care.

Mayo initially launched the system in January 2016. Prior to this, subject matter experts taught the system important patient and tumor characteristics to consider when matching a patient with complex inclusion and exclusion clinical trials; where and how to identify different attributes; and how to collect patient input.

Nurses, physicians and coordinators were also trained on how to use the system, while patients were provided brochures to explain the new method for matching them to clinical trials. According to Haddad, a system support team was also formed.

The system saw little success, however, with growth in clinical trial matches waning after the first week due to the need to perform point-of-care screenings clogging the current workload of nurses and physicians.

“They were doing screenings at 6 AM; they were doing them at 8 PM, after hours; they were doing it on weekends,” said Haddad. “The first week, we could see maybe about 25 percent of patients being screened. But by the second, this decreased to maybe about 15 percent. Our Watson team and the clinic stepped away, and people stopped using it.”

Mayo quickly brought on board a health system engineer to help deconstruct its existing workflow and identify resources at its disposal.
  Pages: 1 - 2 >>

Oncology Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2018, Inc.